Hemovás

Hemovás is a prescription oral medication whose active ingredient is pentoxifylline; the exact strength and dosage form are not specified in the product listing. Pentoxifylline is a phosphodiesterase inhibitor used as a vasodilator to enhance peripheral blood flow. The product is marketed in the European Union and is available only with a prescription, primarily for patients with chronic circulation disorders of the legs and veins.

Hemovás (pentoxifylline) is indicated for several vascular conditions where improved microcirculatory flow is desired.

- Intermittent claudication due to peripheral arterial disease - Chronic venous insufficiency with edema or ulceration - Peripheral vascular disease affecting lower extremities - Adjunctive therapy to reduce blood viscosity in patients with microvascular disorders

Side‑effect profiles for pentoxifylline are generally mild, but some reactions may require medical attention.

Common: - Nausea or upset stomach - Headache - Dizziness or light‑headedness - Flushing or warmth sensation - Diarrhea

Serious: - Severe allergic reaction (rash, itching, swelling, difficulty breathing) - Chest pain or palpitations - Unexplained bleeding or bruising - Low blood pressure causing faintness

Before prescribing Hemovás, clinicians should evaluate several safety considerations.

- Use with caution in patients with recent myocardial infarction or unstable angina - Assess renal or hepatic impairment, as dose adjustment may be needed - Avoid in patients with known hypersensitivity to pentoxifylline or related compounds - Monitor blood pressure in individuals prone to hypotension - Consider potential effects on bleeding risk, especially in those on anticoagulants - Use during pregnancy only if potential benefit justifies potential risk (category unknown)

Pentoxifylline may interact with other medicines, influencing efficacy or safety.

Avoid: - Concurrent use with anticoagulants such as warfarin, due to increased bleeding risk - Combination with other phosphodiesterase inhibitors (e.g., cilostazol) that may amplify vasodilatory effects

Use with caution: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that can increase gastrointestinal irritation - Antihypertensive agents, as additive blood‑pressure lowering may occur - Certain antibiotics (e.g., macrolides) that can affect pentoxifylline metabolism